Johnson Johnson JNJ Secures FDA Priority Review for IMAAVY Targeting FirstofItsKind Indication for Warm Autoimmune Hemolytic Anemia Is Aka Brands AKA stock losing technical support Aka Brands posts 618 EPS miss loss far wider than estimates Is Stardust Power SDST stock worth evaluating for entry Q4 2025 EPS Beats Forecasts